BioNexus Gene Lab (BGLC) Inventory Average (2019 - 2026)

BioNexus Gene Lab has disclosed Inventory Average across 8 years of filings, most recently posting $660023.0 for Q2 2026.

• In Q2 2026, Inventory Average fell 44.88% year-over-year to $660023.0; the TTM figure through Jun 2026 stood at $660023.0 (down 44.88% YoY), while the FY2025 annual figure was $1.0 million, down 18.25% from the prior year.
• Inventory Average came in at $660023.0 for Q2 2026 at BioNexus Gene Lab, down from $671928.5 in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $1.6 million in Q1 2022 to a low of $660023.0 in Q2 2026.
• Average Inventory Average over 5 years is $1.1 million, with a median of $1.1 million recorded in 2023.
• Year-over-year, Inventory Average increased 23.69% in 2024 and sank 47.66% in 2026.
• Over 5 years, Inventory Average stood at $1.0 million in 2022, then advanced by 8.29% to $1.1 million in 2023, then advanced by 23.69% to $1.4 million in 2024, then sank by 39.37% to $842075.5 in 2025, then slipped by 21.62% to $660023.0 in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $660023.0 in Q2 2026, $671928.5 in Q1 2026, and $842075.5 in Q4 2025.